Index of reports
> Cases with Meningitis Aseptic (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carimune NF (Immune Globulin Intravenous) where reactions include meningitis aseptic. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Carimune NF side effects in female
Reported by a physician from United States on 2012-02-07
Patient: female
Reactions: Migraine, Nuchal Rigidity, Pain, Condition Aggravated, Rash, Pyrexia, Hyperhidrosis, Flushing, Meningitis Aseptic
Drug(s) suspected as cause:
Carimune NF
Dosage: see image
Indication: Myasthenia Gravis
Start date: 2009-10-13
Carimune NF
Dosage: see image
Indication: Autonomic Neuropathy
Start date: 2009-10-13
Carimune NF
Dosage: see image
Indication: Immunodeficiency
Start date: 2009-10-13
Carimune NF
Dosage: see image
Indication: Myasthenia Gravis
Start date: 2011-03-01
Carimune NF
Dosage: see image
Indication: Autonomic Neuropathy
Start date: 2011-03-01
Carimune NF
Dosage: see image
Indication: Immunodeficiency
Start date: 2011-03-01
Possible Carimune NF side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-23
Patient: female
Reactions: Migraine, Nuchal Rigidity, Condition Aggravated, Rash, Pyrexia, Blood Immunoglobulin G Decreased, Hyperhidrosis, Flushing, Neck Pain, Meningitis Aseptic
Drug(s) suspected as cause:
Carimune NF
Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
Indication: Myasthenia Gravis
Start date: 2011-03-01
Carimune NF
Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
Indication: Autonomic Neuropathy
Start date: 2011-03-01
Carimune NF
Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
Indication: Immunodeficiency
Start date: 2011-03-01
Carimune NF
Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
Indication: Myasthenia Gravis
Start date: 2009-10-13
Carimune NF
Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
Indication: Autonomic Neuropathy
Start date: 2009-10-13
Carimune NF
Dosage: (intravenous (not otherwise specified)), (120 g, 120 g weekly (2 weeks on and 1 week off) intravenou
Indication: Immunodeficiency
Start date: 2009-10-13
|